HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by TimesSquare Capital Management LLC

TimesSquare Capital Management LLC lessened its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 70.9% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 65,000 shares of the company's stock after selling 158,298 shares during the period. TimesSquare Capital Management LLC owned 0.08% of HealthEquity worth $6,237,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Holocene Advisors LP bought a new position in shares of HealthEquity during the third quarter valued at about $1,246,000. GSA Capital Partners LLP bought a new position in shares of HealthEquity during the third quarter valued at about $638,000. Natixis Advisors LLC grew its stake in shares of HealthEquity by 29.8% during the third quarter. Natixis Advisors LLC now owns 209,175 shares of the company's stock valued at $17,122,000 after buying an additional 48,009 shares during the last quarter. Vaughan Nelson Investment Management L.P. grew its stake in shares of HealthEquity by 36.7% during the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company's stock valued at $69,034,000 after buying an additional 226,563 shares during the last quarter. Finally, Loomis Sayles & Co. L P grew its stake in shares of HealthEquity by 2.2% during the third quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company's stock valued at $92,216,000 after buying an additional 24,665 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.

Insider Activity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares of the company's stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the firm's stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the transaction, the director now directly owns 19,061 shares of the company's stock, valued at approximately $1,843,579.92. This represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 39,000 shares of company stock worth $3,895,788. Corporate insiders own 2.20% of the company's stock.

HealthEquity Trading Down 3.1 %

HQY stock traded down $3.47 during mid-day trading on Friday, reaching $108.25. The company had a trading volume of 261,776 shares, compared to its average volume of 720,651. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The company has a market capitalization of $9.38 billion, a PE ratio of 99.42, a price-to-earnings-growth ratio of 1.63 and a beta of 0.55. The firm has a 50 day moving average of $103.40 and a 200 day moving average of $91.77. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts' consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter in the prior year, the company earned $0.40 earnings per share. On average, equities analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently issued reports on HQY shares. JMP Securities raised their target price on HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research note on Tuesday, December 10th. Royal Bank of Canada raised their target price on HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a research note on Tuesday, December 10th. Mizuho began coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 target price on the stock. Barrington Research lifted their price objective on HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a research report on Monday, December 2nd. Finally, The Goldman Sachs Group began coverage on HealthEquity in a research report on Friday, November 15th. They set a "neutral" rating and a $108.00 price objective on the stock. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $110.71.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.